MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Body mass index

(UMLS:C1305855)

Definition:: An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI=weight (kg)/height squared (m2). BMI correlates with body fat (ADIPOSE TISSUE). Their relationship varies with age and gender. For adults, BMI falls into these categories: below 18.5 (underweight); 18.5-24.9 (normal); 25.0-29.9 (overweight); 30.0 and above (obese). (National Center for Health Statistics, Centers for Disease Control and Prevention)
UMLS ID:: C1305855
MeSH ID:: D015992

Classification 1:

Name:

Diagnosis
MeSH Tree Number(s):: E01.370.600.115.100.125

Classification 2:

Name:

Investigative Techniques
MeSH Tree Number(s):: E05.041.124.125

Classification 3:

Name:

Physiological Phenomena
MeSH Tree Number(s):: G07.100.100.125

Classification 4:

Name:

Notice: Undefined index: N06 in /var/www/metaadedb/ADE.php on line 175

MeSH Tree Number(s):: N06.850.505.200.100.175

Synonym(s)

Body mass index

BMI

BMI - Body mass index

Body Mass Index

Body mass index, NOS

Quetelet Index

Quetelet index

body mass index

body mass index (BMI)

10.

quetelet index

Associated Drug(s)

	Name	Number of Reports	Reference(s)	Data Source
1	Testosterone	FAERS: 2		US FAERS
2	Olmesartan Medoxomil	FAERS: 1		US FAERS

Similar ADE(s)

	Name	Semantic Similarity
1	Body Height	27.5%
2	Body Weight	24.8%
3	Birth Weight	20.4%
4	Fetal Weight	17.5%
5	Underweight	17%
6	Overweight	17%
7	Obesity, Abdominal	14.4%
8	Obesity	13.4%
9	Pediatric Obesity	12.6%
10	Body Temperature	11.5%
11	Apgar Score	11.4%
12	Auscultation	11.4%
13	Autopsy	11.4%
14	Disease susceptibility	9.9%
15	Facies	9.6%
16	Cytogenetic Analysis	8.5%
17	Microscopy	8.5%
18	Electroencephalogram	8.2%
19	Biopsy	7.9%
20	Abnormal Involuntary Movement Scale	6.8%
21	Device Failure	6.8%
22	Electrophoresis	6.7%
23	angiogram	6.5%
24	Electrocardiogram	6.5%
25	Glucose tolerance test	6.3%
26	Amniocentesis	6%
27	Intubation	5.8%
28	Blood Pressure	5.7%
29	heart rate	5.7%
30	Respiratory rate	5.7%
31	Laryngoscopy	5%
32	Bronchoscopy	4.9%
33	Cystoscopy	4.9%
34	Environmental Exposure	4.9%
35	Water Pollution	4.9%
36	Blood culture	4.6%
37	Endoscopic Retrograde Cholangiopancreatography	4.6%
38	Colposcopy	4.4%
39	Hysteroscopy	4.4%
40	Tuberculin Test	4.2%
41	Capillary Fragility	4.1%
42	Gastric Lavage	4%
43	Peritoneal lavage	4%
44	Bronchoalveolar Lavage	4%
45	Breast Feeding	3.9%
46	Valsalva Maneuver	3.7%
47	Reflex, Abnormal	3.6%
48	Hyporeflexia	3.6%
49	Hyperreflexia	3.6%
50	Drowning	3.6%
51	Pleural Rub	3.6%
52	Rales	3.6%
53	Respiratory Sounds	3.6%
54	Rhonchi	3.6%
55	Stridor	3.6%
56	Wheezing	3.6%
57	Oxidative Stress	3.4%
58	Radiation Injuries, Experimental	3.4%
59	Glasgow coma scale	3.4%
60	Prosthesis Failure	3.3%
61	Sweating	3.3%
62	Immunosuppression	3.3%
63	Radiation injury	3.1%
64	Paracentesis	2.9%
65	PROTHROMBIN TIME	2.8%
66	Fasting	2.8%
67	Shivering	2.8%
68	Clot retraction	2.8%
69	Drug resistance	2.6%
70	Drug Tolerance	2.6%
71	Polymerase Chain Reaction	2.6%
72	Angioplasty	2.5%
73	Glomerular Filtration Rate	2.5%
74	Near Drowning	2.5%
75	venipuncture	2.5%
76	Cardiac Output	2.4%
77	Laparoscopy	2.4%
78	Multimorbidity	2.4%
79	Anion Gap	2.3%
80	Neoplasms, Experimental	2.3%
81	Bottle feeding	2.3%
82	Liver Cirrhosis, Experimental	2.2%
83	Ovulation Induction	2.2%
84	Arthritis, Experimental	2.2%
85	Immunoglobulin Therapy	2.2%
86	Arthroscopy	2.1%
87	Mediastinoscopy	2.1%
88	colonoscopy	2.1%
89	Proctoscopy	2.1%
90	Leukapheresis	2%
91	Abnormalities, Radiation-Induced	1.9%
92	Hunger	1.9%
93	Diabetes Mellitus, Experimental	1.9%
94	Patient Isolation	1.7%
95	Diapedesis	1.6%
96	Total Lung Capacity	1.6%
97	Tachyphylaxis	1.6%
98	Atherectomy	1.6%
99	Maximal Voluntary Ventilation	1.6%
100	Barium Enema	1.6%
101	Somatosensory Evoked Potentials	1.6%
102	Insulin Resistance	1.6%
103	Leukemia, Experimental	1.4%
104	Mammary Neoplasms, Experimental	1.4%
105	Sarcoma, Experimental	1.4%
106	Superovulation	1.4%
107	Body Weight Changes	1.4%
108	Ketogenic Diet	1.3%
109	Neuritis, Autoimmune, Experimental	1.2%
110	Weight Gain	1.2%
111	Peak expiratory flow rate	1.2%
112	treatment failure	1.2%
113	Liver Neoplasms, Experimental	1.1%
114	Melanoma, Experimental	1.1%
115	Myasthenia Gravis, Autoimmune, Experimental	1%
116	Tidal Volume	0.9%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120238